Table 2. Summary of hazard ratios of lncRNA expression in cervical cancer.

lncRNAs	Reference	Case number			OS		DFS/RFS
		High expression	Low expression	HR (95% CI)		P Value	HR (95% CI)	P Value
HOTAIR	Long Huang, 2014	109	109	4.57 (2.12–9.85)		< 0.001	2.98 (1.62–5.45)*	0.0004
HOTAIR	Jing Li, 2014	59	59	3.15 (1.44–6.88)*		0.004	2.11 (1.18–3.77)*	0.012
HOTAIR	Hee Jung Kim, 2015	89	22	5.28 (1.01–27.75)		0.049	NM	NM
PVT1	Shaorong Zhang, 2016	45	45	1.97 (1.14–3.40)*		0.015	NM	NM
PVT1	Marissa Iden, 2016	63	58	1.73 (1.05–2.84)*		0.03	NM	NM
XLOC_010588	Lingmin Liao, 2014	109	109	0.37 (0.17–0.75)		0.006	0.45(0.25–0.83)*	0.008
GAS5	Shihong Cao, 2014	58	44	3.22 (1.68–6.17)		< 0.001	NM	NM
MALAT1	L. Yang, 2015	52	52	2.21 (1.08–4.56)		0.031	2.60 (1.60–4.23)*	0.0001
CCHE1	Meng Yang, 2015	91	91	2.27 (1.30–3.96)*		0.004	1.23 (1.10–1.38)*	0.0004
XIST	Reiko Kobayashi, 2015	24	25	0.27 (0.08–0.86)		0.027	NM	NM
LET	Shan Jiang, 2015	44	50	0.40 (0.22–0.73)		0.003	NM	NM
HULC	Y.F. Wang, 2016	120	124	1.88 (1.29–2.74)*		0.001	NM	NM
HOXA11	Hee Jung Kim, 2016	41	51	2.45 (1.08–5.56)		0.032	NM	NM
MEG3	Jun Zhang, 2017	36	36	0.33 (0.15–0.72)*		0.005	0.16 (0.03–0.92)	0.04
ANRIL	Dongli Zhang, 2017	27	26	3.23 (1.42–7.32)*		0.005	NM	NM